142 related articles for article (PubMed ID: 3030349)
1. Epstein-Barr virus seroepidemiology in China.
Zeng Y; Pi GH; Deng H; Zhang JM; Wang PC; Wolf H; De Thé G
AIDS Res; 1986 Dec; 2 Suppl 1():S7-15. PubMed ID: 3030349
[TBL] [Abstract][Full Text] [Related]
2. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
3. Serological survey of nasopharyngeal carcinoma in 21 cities of south China.
Deng H; Zeng Y; Lei Y; Zhao Z; Wang P; Li B; Pi Z; Tan B; Zheng Y; Pan W
Chin Med J (Engl); 1995 Apr; 108(4):300-3. PubMed ID: 7789220
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implication of pretreatment titer of serum immunoglobulin A against Epstein-Barr virus capsid antigen in nasopharyngeal carcinoma patients in Sihui, Guangdong.
Ling W; Cao SM; Huang QH; Li YH; Deng MQ
Ai Zheng; 2009 Jan; 28(1):57-9. PubMed ID: 19448418
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
Liu MT; Yeh CY
Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
[TBL] [Abstract][Full Text] [Related]
6. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
Levine PH; Pearson GR; Armstrong M; Bengali Z; Berenberg J; Easton J; Goepfert H; Henle G; Henle W; Heffner D; Huang A; Hyams VJ; Lanier A; Neel HB; Pilch B; Pointek N; Taylor W; Terebelo H; Weiland L
Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561
[TBL] [Abstract][Full Text] [Related]
7. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
[TBL] [Abstract][Full Text] [Related]
8. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
Karray H; Ayadi W; Fki L; Hammami A; Daoud J; Drira MM; Frikha M; Jlidi R; Middeldorp JM
J Med Virol; 2005 Apr; 75(4):593-602. PubMed ID: 15714486
[TBL] [Abstract][Full Text] [Related]
9. [Immunoglobulin A serum antibodies against the capsid antigen of Epstein-Barr virus in the differential diagnosis and follow-up of nasopharyngeal cancer].
Pavelka R; Popow-Kraupp T; Radaszkiewicz T
Wien Klin Wochenschr; 1985 Jul; 97(14):588-95. PubMed ID: 2996246
[TBL] [Abstract][Full Text] [Related]
10. [Gene engineering EB virus membrane antigen in detection of MA-IgA antibody--comparison with VCA-IgA and EA-IgA antibodies].
Liu MZ
Zhonghua Zhong Liu Za Zhi; 1990 Jul; 12(4):288-90. PubMed ID: 2176967
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
[TBL] [Abstract][Full Text] [Related]
12. Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China.
Zeng Y; Zhang LG; Wu YC; Huang YS; Huang NQ; Li JY; Wang YB; Jiang MK; Fang Z; Meng NN
Int J Cancer; 1985 Nov; 36(5):545-7. PubMed ID: 4055129
[TBL] [Abstract][Full Text] [Related]
13. Serological follow-up study on the antibody levels to Epstein-Barr virus-determined nuclear antigen (EBNA) patients with nasopharyngeal carcinoma (NPC) after radiation therapy.
Shimakage M; Ikegami N; Chatani M; Yoshino K; Sato T
Biken J; 1987 Jun; 30(2):45-51. PubMed ID: 2830879
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review.
Tsang RK; Vlantis AC; Ho RW; Tam JS; To KF; van Hasselt CA
Head Neck; 2004 Jul; 26(7):598-602. PubMed ID: 15229902
[TBL] [Abstract][Full Text] [Related]
15. Follow-up studies on Epstein-Barr virus IgA/VCA antibody-positive persons in Zangwu County, China.
Zeng Y; Zhong JM; Li LY; Wang PZ; Tang H; Ma YR; Zhu JS; Pan WJ; Liu YX; Wei ZN
Intervirology; 1983; 20(4):190-4. PubMed ID: 6317603
[TBL] [Abstract][Full Text] [Related]
16. [A dynamic study on titer of EB virus VCA/IgA and EA/IgA in nasopharygeal carcinoma patients].
Ji MF; Guo YQ; Liang JS; Zheng SA; Cheng WM; Yu BH; Ou XT; Wang DK
Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):243-5. PubMed ID: 12839685
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of multiple antibodies to Epstein-Barr virus as markers for detecting patients with nasopharyngeal carcinoma.
Liu MY; Chang YL; Ma J; Yang HL; Hsu MM; Chen CJ; Chen JY; Yang CS
J Med Virol; 1997 Jul; 52(3):262-9. PubMed ID: 9210034
[TBL] [Abstract][Full Text] [Related]
18. [Significance of detection of serum sialic acid and Epstein-Barr virus VCA-IgA in diagnosis and monitoring radiotherapy effectiveness in nasopharyngeal carcinoma patients].
Jiang LN; Dai LC; He JF; Chen YW; Ma ZH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):30-2. PubMed ID: 16816858
[TBL] [Abstract][Full Text] [Related]
19. [The usefulness of serum antibody to Epstein-Barr virus-specific DNAase (EDAb) in early detection of nasopharyngeal carcinoma].
Huang D
Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):289-91. PubMed ID: 8174467
[TBL] [Abstract][Full Text] [Related]
20. [Early diagnosis of nasopharyngeal carcinoma using recombinant antigens expressed in bacteria].
Wan Z; Pi G; Sun N
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):74-6. PubMed ID: 12515179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]